1Criffin MR. Epidemiology of nonsteroidal anti- in- flammatory drug- associated gastrointestinal injury E J]. American Journal of Medicine, 1998, 104 (3) .. 23S - 29S.
2Dineer D, Duman A, Dikiei H, et al. NSAID - related upper gastrointestinal bleeding:are risk factors con- sidered during prophylaxis.'? [J]. International Journal of Clinical Practice,2006,60(5) :546- 548.
3Yamamoto T, Mishina Y, Ebato T, e*_ al. Prevalence of erosive esophagitis among Japanese patients taking low- dose aspirin[J]. J Gastroenterol Hepato,2010, 25 792 - 794.
4Scheiman JM, Yeomans ND,Talley N J, et al. Preven tion of ulcers by esomeprazole in at- risk patients u- sing non- selective NSAIDs and COX - 2 inhibitors [J]. American Journal of Gastroenterology,2006,104 (4) ..701 - 710.
5You JH,Lau W,I.ee 1Y,et al. Helicobacter pylori e radication prior to initiation of long- term non- ster- oidal anti- inflammatory drug therapy in chinese pa- tients- a cost- effectiveness analysis [J]. Deutsche Medizinisehe Wochenschrift, 2006, 108 (38) : 1453 - 1454.
